VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market
Holding VYNE?
Track your performance easily

VYNE Therapeutics (VYNE) Technical Analysis

1,810 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
4Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
VYNE Therapeutics’s (VYNE) Moving Averages Convergence Divergence (MACD) indicator is -0.08, suggesting VYNE Therapeutics is a Sell.
VYNE Therapeutics’s (VYNE) 20-Day exponential moving average is 2.02, while VYNE Therapeutics’s (VYNE) share price is $2.25, making it a Buy.
VYNE Therapeutics’s (VYNE) 50-Day exponential moving average is 2.20, while VYNE Therapeutics’s (VYNE) share price is $2.25, making it a Sell.

VYNE Therapeutics (VYNE) Pivot Points

Nov 05, 2024, 10:20 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.75
1.82
1.95
2.02
2.15
2.22
2.35
Fibonacci
1.82
1.90
1.95
2.02
2.10
2.15
2.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

VYNE Therapeutics (VYNE) Moving Averages

Nov 05, 2024, 10:20 AM
Period
Simple
Exponential
MA5
2.01Buy
2.03Buy
MA10
1.94Buy
1.98Buy
MA20
1.95Buy
2.02Buy
MA50
2.33Sell
2.20Sell
MA100
2.39Sell
2.37Sell
MA200
2.59Sell
2.78Sell
VYNE Therapeutics’s (VYNE) 10-Day exponential moving average is 1.98, while VYNE Therapeutics’s (VYNE) share price is $2.25, making it a Buy.
VYNE Therapeutics’s (VYNE) 100-Day exponential moving average is 2.37, while VYNE Therapeutics’s (VYNE) share price is $2.25, making it a Sell.
VYNE Therapeutics’s (VYNE) stock price is $2.25 and VYNE Therapeutics’s (VYNE) 50-day simple moving average is 2.33, creating a Sell signal.
VYNE Therapeutics’s (VYNE) stock price is $2.25 and VYNE Therapeutics’s (VYNE) 100-day simple moving average is 2.39, creating a Sell signal.
VYNE Therapeutics’s (VYNE) stock price is $2.25 and VYNE Therapeutics’s (VYNE) 200-day simple moving average is 2.59, creating a Sell signal.

VYNE Therapeutics (VYNE) Technical Indicators

Nov 05, 2024, 10:20 AM
Name
Value
Implied Action
RSI (14)
53.21
Neutral
STOCH (9,6)
86.58
Sell
STOCHRSI (14)
82.17
Sell
MACD (12,26)
-0.08
Sell
ADX (14)
25.65
Neutral
Williams %R
0.00
-
CCI (14)
75.94
Neutral
ATR (14)
0.18
-
Ultimate Oscillator
61.76
Neutral
ROC
17.58
Buy
VYNE Therapeutics’s (VYNE) Relative Strength Index (RSI) is 53.21, creating a Neutral signal.
VYNE Therapeutics’s (VYNE) Trend Strength Indicator (ADX) is 25.65, creating a Neutral signal.
VYNE Therapeutics’s (VYNE) Commodity Channel Index (CCI) is 75.94, creating a Neutral signal.
VYNE Therapeutics’s (VYNE) Price Rate of Change (ROC) is 17.58, creating a Buy signal.

FAQ

Is VYNE a Buy, Hold, or Sell?
Based on VYNE’s technical indicators, VYNE is a Hold.
    What is VYNE’s RSI (14)?
    VYNE’s RSI (14) is 53.21, which suggests VYNE is a Neutral.
      What is VYNE’s MACD?
      VYNE’s MACD is -0.08, which suggests VYNE is a Sell.
        What is VYNE’s 5-day moving average?
        VYNE’s 5-day moving average is 2.01, which suggests VYNE is a Buy.
          What is VYNE’s 20-day moving average?
          VYNE 20-day moving average is 1.95, which suggests VYNE is a Buy.
            What is VYNE’s 50-day moving average?
            VYNE’s 50-day moving average is 2.33, which suggests VYNE is a Sell.
              What is VYNE’s 200-day moving average?
              VYNE’s 200-day moving average is 2.59, which suggests VYNE is a Sell.
                What is VYNE’s Williams % R (14)?
                Currently, no data Available
                What is VYNE’s CCI (14)?
                VYNE’s CCI (14) is 75.94, which suggests VYNE is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis